Published in AIDS Weekly, November 8th, 1999
P.R. Harrigan and colleagues performed a study to determine whether baseline drug resistance assays could help to predict treatment failure with the protease inhibitor combination ritonavir-saquinavir ("Baseline HIV Drug Resistance Profile Predicts Response to Ritonavir-Saquinavir Protease Inhibitor Therapy in a Community Setting," AIDS, October 1, 1999;13(14):1863-1871).
The researchers determined baseline HIV-1 drug resistance for 76 consecutive patients who started treatment with the dual protease inhibitor combination...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.